FB2026_02 , released June 18, 2026
Human Disease Model Report: autism spectrum disorder, susceptibility to, NRXN-related
Open Close
General Information
Name
autism spectrum disorder, susceptibility to, NRXN-related
FlyBase ID
FBhh0000516
OMIM
Overview

The human genes NRXN1, NRXN2, and NRXN3 have been identified as high-confidence candidate susceptibility loci for autism spectrum disorder (SFARI Gene, see below; see also discussion in MIM:209850). Each encodes a single-pass membrane protein that belongs to the neurexin family; the neurexin/neuroligin complex is present at neural synapses and is required for efficient neurotransmission and in the formation of synaptic contacts. There is a single orthologous gene in Drosophila, Dmel\Nrx-1, for which classical amorphic alleles, RNAi targeting constructs, and alleles caused by insertional mutagenesis have been generated. Dmel\Nrx-1 is also orthologous to an additional neurexin gene in human, NRXN4. NRXN1 has also been implicated in Pitt-Hopkins-like syndrome 2 (MIM:614325) and a deletion syndrome associated with susceptibility to schizophrenia (MIM:614332).

Multiple UAS constructs of the human Hsap\NRXN1 gene has been introduced into flies, including wild-type and variants implicated in ASD. See the 'Disease-Implicated Variants' table below.

Animals homozygous for amorphic mutations of Dmel\Nrx-1 typically die before reaching adult stage; larvae exhibit locomotor, neuroanatomy, and neurophysiology defects. RNAi-effected loss of function leads to reduced behavioral flexibility in adults, as shown by severe reversal-learning impairment; it is postulated that this phenotype results from the failure to properly activate Rac1-dependent forgetting. Genetic and physical interactions for Dmel\Nrx-1 have been described; see below and in the Nrx-1 gene report.

NRXN1 is one of a number of genes in human that have been implicated in both autism spectrum disorder and schizophrenia. See the human disease model report 'autism co-occurence with schizophrenia' (FBhh0001356).

[updated Jan. 2022 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: autism spectrum disorder, susceptibility to
Symptoms and phenotype

Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996, pubmed:8655659; Risch et al., 1999, pubmed:10417292). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (MIM:608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Mental retardation coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which mental retardation is conspicuously absent (Jones et al., 2008; pubmed:18698615). [from MIM:209850; 2017.03.18]

Specific Disease Summary: autism spectrum disorder, susceptibility to, NRXN-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics

The SFARI Gene autism database ( https:gene.sfari.org ) rates the gene-autism associations for NRXN1, NRXN2, and NRXN3 as high confidence (score 1). [2020.11.05]

Cellular phenotype and pathology
Molecular information

NRXN1 gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. [Gene Cards, NRXN1; 2017.03.18]

Neuroligins function as ligands for the neurexins, which are cell-surface receptors. The Ca(2+)-dependent neurexin/neuroligin complex is present at synapses in the central nervous system, is required for efficient neurotransmission, and is involved in the formation of synaptic contacts (summary by Reissner et al., 2008; pubmed:18812509). [from MIM:600568; 2017.03.18]

External links
Disease synonyms
autism spectrum disorder, susceptibility to (postulated), NRXN1-related
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
Symbol / Name
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 3 human to 1 Drosophila. The other human genes are NRXN2 and NRXN3.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Neurexin 1 (Nrx-1) encodes a transmembrane synaptic adhesive molecule that regulates the synaptic architecture and function in the brain and neuromuscular junction. It contributes to synaptic growth, transmission, synaptic formation and also regulation of learning and memory, locomotion and visual function. [Date last reviewed: 2019-03-14]
    Gene Groups / Pathways
      Comments on ortholog(s)

      High-scoring ortholog of human NRXN1, NRXN2 and NRXN3 (1 Drosophila to 3 human). Dmel\Nrx-1 shares 32-33% identity and 47-49% similarity with the human genes.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (14 groups)
        RNA-protein
        Interacting group
        Assay
        References
        anti bait coimmunoprecipitation, quantitative reverse transcription pcr
        protein-protein
        Interacting group
        Assay
        References
        anti bait coimmunoprecipitation, western blot, pull down, two hybrid
        pull down, western blot, two hybrid, anti bait coimmunoprecipitation
        pull down, western blot, two hybrid, anti bait coimmunoprecipitation
        anti tag coimmunoprecipitation, anti tag western blot
        anti bait coimmunoprecipitation, western blot, pull down, molecular weight estimation by staining, two hybrid
        anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        isothermal titration calorimetry, predetermined participant, two hybrid, anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, anti tag western blot
        anti tag coimmunoprecipitation, western blot, pull down
        two hybrid, isothermal titration calorimetry, predetermined participant, x-ray crystallography, anti bait coimmunoprecipitation, western blot, pull down, molecular weight estimation by staining
        anti tag coimmunoprecipitation, anti tag western blot
        Alleles Reported to Model Human Disease (Disease Ontology) (11 alleles)
        Models Based on Experimental Evidence ( 5 )
        Modifiers Based on Experimental Evidence ( 4 )
        Models Based on Experimental Evidence ( 4 )
        Modifiers Based on Experimental Evidence ( 0 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        P-element activity
        amorphic allele - molecular evidence
        P-element activity
        Delta2-3 transposase
        Delta2-3 transposase
        References (20)